These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1857319)

  • 21. Use of methylphenidate for attention deficit hyperactivity disorder. Mental Health Committee, Canadian Paediatric Society.
    CMAJ; 1990 Apr; 142(8):817-8. PubMed ID: 2322913
    [No Abstract]   [Full Text] [Related]  

  • 22. Attention deficit hyperactivity disorder in children.
    Pritchard D
    Clin Evid; 2005 Jun; (13):266-79. PubMed ID: 16135263
    [No Abstract]   [Full Text] [Related]  

  • 23. Attention deficit hyperactivity disorder in children.
    Pritchard D
    Clin Evid; 2006 Jun; (15):331-44. PubMed ID: 16973014
    [No Abstract]   [Full Text] [Related]  

  • 24. Ten years of experience with 1,000 hyperactive children in a private practice.
    Eichlseder W
    Pediatrics; 1985 Aug; 76(2):176-84. PubMed ID: 4022690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attention deficit hyperactivity disorder.
    Ramchandani P; Joughin C; Zwi M
    Clin Evid; 2003 Jun; (9):318-27. PubMed ID: 12967364
    [No Abstract]   [Full Text] [Related]  

  • 26. Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
    Fone KC; Nutt DJ
    Curr Opin Pharmacol; 2005 Feb; 5(1):87-93. PubMed ID: 15661631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The hyperactive child.
    Chapel JL
    Mo Med; 1973 Nov; 70(11):768-74. PubMed ID: 4753031
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of stimulant medications in children.
    Morgan AM
    Am Fam Physician; 1988 Oct; 38(4):197-202. PubMed ID: 3051976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adolescent outcome of hyperactive children treated with stimulants in childhood: a review.
    Hechtman L
    Psychopharmacol Bull; 1985; 21(2):178-91. PubMed ID: 2860690
    [No Abstract]   [Full Text] [Related]  

  • 30. Increased urine phenylethylamine after methylphenidate treatment in children with ADHD.
    Kusaga A; Yamashita Y; Koeda T; Hiratani M; Kaneko M; Yamada S; Matsuishi T
    Ann Neurol; 2002 Sep; 52(3):372-4. PubMed ID: 12205654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapy of hyperkinetic syndrome is many-sided. Interview by Dr. med. Fritz Schnitger].
    Blank R
    Kinderarztl Prax; 1993 May; 61(3):122-3. PubMed ID: 8326702
    [No Abstract]   [Full Text] [Related]  

  • 32. Methylphenidate HCl: therapy for attention deficit hyperactivity disorder.
    Capp PK; Pearl PL; Conlon C
    Expert Rev Neurother; 2005 May; 5(3):325-31. PubMed ID: 15938665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current strategies in the diagnosis and treatment of childhood attention-deficit/hyperactivity disorder.
    Rader R; McCauley L; Callen EC
    Am Fam Physician; 2009 Apr; 79(8):657-65. PubMed ID: 19405409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract]   [Full Text] [Related]  

  • 35. Drugging unruly children is a method of social control.
    Rose S
    Nature; 2008 Jan; 451(7178):521. PubMed ID: 18235481
    [No Abstract]   [Full Text] [Related]  

  • 36. Stimulant treatment of adult attention-deficit/hyperactivity disorder.
    Spencer T; Biederman J; Wilens T
    Psychiatr Clin North Am; 2004 Jun; 27(2):361-72. PubMed ID: 15064002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attention-deficit/hyperactivity disorder: a life-span perspective.
    Biederman J
    J Clin Psychiatry; 1998; 59 Suppl 7():4-16. PubMed ID: 9680048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mood-altering drugs and hyperkinetic children.
    Erenberg G
    Pediatrics; 1972 Feb; 49(2):308-11. PubMed ID: 5059542
    [No Abstract]   [Full Text] [Related]  

  • 39. [Medication for ADHD and the risk of cardiovascular mortality].
    Langendijk PN; Wilde AA
    Ned Tijdschr Geneeskd; 2006 Aug; 150(31):1713-4. PubMed ID: 16924941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Malnutrition in children with DAMP?].
    Andersen LL
    Ugeskr Laeger; 2009 Mar; 171(10):824. PubMed ID: 19280776
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.